TNF and COVID-19: As increased serum levels of TNF alpha have been detected in many patients with severe COVID-19 compared to subjects with mild disease, the use of TNF-α inhibitors was proposed at the beginning of the outbreak with therapeutic purpose against COVID-19 [43,70].